GlaxoSmithKline Pharmaceuticals Limited announced the re-appointment of Sridhar Venkatesh as Managing Director of the company for a period of one year from 1st April 2022 to 31st March 2023.
Sridhar Venkatesh is a senior business leader with more than 28 years of diverse experience in pharmaceuticals and healthcare. He joined GSK in 2011 as Head of Commercial, Established Products, Branded Generics, & Biosimilars. He held the role of General Manager, Singapore before taking up the role of Commercial Head, India, from 2014 to 2016. He was then appointed as Vice President of Central America & Caribbean before taking on the current role of Vice President, Emerging Markets East, managing direct oversight of six markets (Philippines, Vietnam, Thailand, Malaysia, Indonesia and Sri Lanka).
Sridhar started his career with Eli Lilly and then moved to Pfizer, holding increasingly senior roles including the role of Senior Director, Business Development (Asia) for Pfizer before joining GSK. Mr. Sridhar is a Registered Pharmacist, with a Master’s in Pharmacy (Pharmaceutical Marketing).
Sridhar Venkatesh was first appointed as a Managing Director from 1st April 2020 to 31 st March 2022. He does not hold any shares in the Company, the statement said.
